Episode 454: Pulmonary Hypertension
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Episode 454: Pulmonary Hypertension” inside PodZeus.
This episode of The Clinical Problem Solvers presents a complex case of a 79-year-old woman with progressive fatigue, shortness of breath, and syncope who was referred to a pulmonary hypertension clinic. She had chronic hypoxemic respiratory failure on 5 liters of oxygen, a history of right heart failure, and was found to have severe pulmonary hypertension with elevated pulmonary artery pressures and normal pulmonary capillary wedge pressure—indicating pre-capillary disease. Despite aggressive management with diuresis and inotropes, her condition deteriorated rapidly. The key diagnostic dilemma arose when she worsened after starting epoprostenol, a pulmonary vasodilator, which is typically used in pulmonary arterial hypertension (PAH). This paradoxical deterioration raised suspicion for pulmonary veno-occlusive disease (PVOD), a rare and often fatal form of pulmonary hypertension that mimics PAH but is contraindicated for vasodilator therapy. The team ultimately concluded that PVOD was the likely diagnosis, supported by her isolated low DLCO, lack of alternative etiology, and clinical trajectory. The episode underscores the critical importance of recognizing PVOD, which can be easily missed due to its similarity to PAH and the risk of life-threatening pulmonary edema from inappropriate vasodilator use.
PVOD is a rare but deadly form of pulmonary hypertension that mimics PAH clinically and hemodynamically but worsens with pulmonary vasodilators.
A normal pulmonary capillary wedge pressure with elevated pulmonary artery pressure suggests pre-capillary pulmonary hypertension, but does not rule out PVOD.
The presence of isolated low DLCO, especially in a patient with chronic hypoxemia, should raise suspicion for underlying vascular or parenchymal lung disease.
Never assume a diagnosis of PAH without ruling out PVOD, especially when vasodilator therapy leads to clinical deterioration.
High-resolution CT chest is essential in evaluating chronic hypoxemia and pulmonary hypertension to detect subtle findings like interlobular septal thickening and central nodules characteristic of PVOD.
…and 2 more takeaways available in PodZeus
Introduction and Case Presentation
The episode opens with a warm welcome from Maddy and Yusuf, setting the stage for a live virtual morning report. The case is introduced by Mark, a hospitalist at Stanford, who presents a 79-year-old woman with progressive fatigue, syncope, and a recent transfer from a pulmonary hypertension clinic. The patient’s history includes chronic hypoxemia, AFib, and prior hospitalization for right heart failure. The team begins to explore the differential diagnosis, focusing on the significance of syncope in a patient with pulmonary hypertension.
Diagnostic Framework and Initial Workup
“The one thing that stuck out to me is I'm like... whoa, why is this patient on five liters at baseline? Like what is going on there, right?”
Right Heart Catheterization and Hemodynamic Patterns
“This patient's RA pressure is 17 and his patient's wedge is five. So that reversal shows that the RV is doing really bad, right?”
Differential Diagnosis and the PVOD Hypothesis
“In PVOD, these pulmonary vasodilators cause this life-threatening pulmonary edema. They are almost indistinguishable on echo findings... but the treatments are like, you know, in one, in PAH, the pulmonary vasodilators can be helpful. And in PVOD, they are really not.”
Clinical Deterioration and Final Diagnosis
“The takeaway is it's a rare form of pulmonary hypertension, but it's very deadly and exactly based on the pathophysiology that Yusuf mentioned, pulmonary vasodilators cause this worsening because you get dilation of the pulmonary artery and then basically that enhances flow upstream to the site of obstruction and then get this life-starting pulmonary edema.”
“In PVOD, these pulmonary vasodilators cause this life-threatening pulmonary edema. They are almost indistinguishable on echo findings... but the treatments are like, you know, in one, in PAH, the pulmonary vasodilators can be helpful. And in PVOD, they are really not.”
“The takeaway is it's a rare form of pulmonary hypertension, but it's very deadly and exactly based on the pathophysiology that Yusuf mentioned, pulmonary vasodilators cause this worsening because you get dilation of the pulmonary artery and then basically that enhances flow upstream to the site of obstruction and then get this life-starting pulmonary edema.”
“This patient's RA pressure is 17 and his patient's wedge is five. So that reversal shows that the RV is doing really bad, right?”
Hosts
Guest
pulmonary hypertension
other
Yusuf
person
Mark
person
Noah
person
Maddy
person
pulmonary veno-occlusive disease
other
right heart catheterization
other
WHO groups
other
epoprostenol
product
pulmonary arterial hypertension
other
Episode 453 – RLR – How do the dots connect?
The Clinical Problem Solvers • 36m • 4/6/2026
Episode 455 – Spaced Learning Series: Abdominal pain and distension
The Clinical Problem Solvers • 45m • 4/29/2026
Episode 456 – RLR – A moving target
The Clinical Problem Solvers • 56m • 5/4/2026
Episode 457 – The Clinical Unknown Series with Dr. Ravi Singh
The Clinical Problem Solvers • 1h 3m • 5/8/2026
Episode 458 – A Case & The Book – Rabih and Reza discuss with Dr. Daniel Kelmenson, a patient with severe hypoxemia
The Clinical Problem Solvers • 40m • 5/13/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Episode 454: Pulmonary Hypertension” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime
